Perhaps most promisingly, emerging biomarkers-particularly interleukin-6, interleukin-10, and procalcitonin-have substantially enhanced our ability to stratify infection risk, demonstrating sensitivity exceeding 85% for bacteraemia detection. This evidence concerns the gene IL6 and infection.